Filing Details
- Accession Number:
- 0001179110-17-015779
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-12-21 15:07:40
- Reporting Period:
- 2017-09-13
- Accepted Time:
- 2017-12-21 15:07:40
- Original Submission Date:
- 2017-09-15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
855654 | Immunogen Inc | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1177813 | Craig Barrows | 22 Chesnut Street Salem MA 01970 | Executive Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-13 | 20,000 | $4.50 | 191,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-13 | 14,600 | $6.95 | 176,900 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-09-15 | 30,000 | $4.50 | 206,900 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-15 | 22,450 | $6.73 | 184,450 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-09-13 | 20,000 | $4.50 | 20,000 | $4.50 |
Common Stock | Stock Option (right to buy) | Disposition | 2017-09-15 | 30,000 | $4.50 | 30,000 | $4.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2008-10-03 | 2017-10-03 | No | 4 | M | Direct |
0 | 2008-10-03 | 2017-10-03 | No | 4 | M | Direct |
Footnotes
- Exercisable as to 12,500 shares commencing on October 3, 2008, 12,500 shares commencing on October 3, 2009, 12,500 shares commencing on October 3, 2010 and 12,500 shares commencing on October 3, 2011.
- Weighted average price of shares sold.
- This amendment to Form 4 is being filed to correct the total shares held to include restricted shares which were inadvertently excluded from the totals in the original Form 4 filed on September 15, 2017.